Delta Air Lines (DAL) expects strong travel demand in 2025 alongside demand in premium 1 year ago Shares of Delta Air Lines (NYSE: DAL) soared over 10% on Friday after the company delivered better-than-expected earnings results for… Key highlights from Constellation Brands’ (STZ) Q3 2025 earnings results 1 year ago Constellation Brands, Inc. (NYSE: STZ) reported its third quarter 2025 earnings results today. Net sales of $2.46 billion remained flat… WBA Earnings: Walgreens Boots Alliance reports higher Q1 sales; results beat 1 year ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Friday reported an increase in net sales for the first quarter of 2025.… DAL Earnings: All you need to know about Delta Air Lines’ Q4 2024 earnings results 1 year ago Delta Air Lines (NYSE: DAL) reported its fourth quarter 2024 earnings results today. Total operating revenue increased 9% year-over-year to… AMD makes big strides in AI chip space. Is the stock a buy? 1 year ago Advanced Micro Devices, Inc. (NASDAQ: AMD) is experiencing a steady increase in the demand for its artificial intelligence chips and… A look at how Conagra Brands (CAG) is navigating a challenging environment 1 year ago Conagra Brands’ (NYSE: CAG) stock has dropped 9% over the past three months. The company has been facing a challenging… Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note 1 year ago UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next… Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities 1 year ago Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over… AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8% 1 year ago AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues… NeOnc Technologies plans to go public through direct listing 1 year ago NeOnc Technologies Holdings Inc., a privately held clinical-stage biotechnology company that develops therapies to improve the treatment of brain tumors… Next» « Previous